Ocrelizumab is a humanized monoclonal antibody used to treat adults with relapsing forms of multiple sclerosis (MS) and primary progressive MS. It is believed to work by targeting CD20-positive B cells, which are thought to be involved in the inflammation and nerve damage caused by MS. Ocrelizumab is given intravenously every 6 months and can reduce the frequency of relapses and slow the progression of disability in people with MS. Common side effects include infusion reactions, upper respiratory tract infections, and headache.
Ocrelizumab, sold under the brand name Ocrevus, is a prescription medication classified as a monoclonal antibody. It's primarily used to treat specific autoimmune diseases. Here's a closer look at its characteristics:
Function:
- Targets B-cells: Ocrelizumab binds to a protein (CD20) present on the surface of certain B-cells, a type of white blood cell involved in the immune system's antibody production.
- Depletes B-cells: By attaching to CD20, Ocrelizumab essentially flags these B-cells for destruction. This leads to a depletion of B cells in the body.
Applications:
- Multiple Sclerosis (MS): Ocrelizumab is approved for treating relapsing forms of multiple sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. In MS, the immune system mistakenly attacks the body's myelin sheath, the protective layer surrounding nerve fibers. By reducing B-cells, Ocrelizumab helps to suppress the immune response and potentially slow down the progression of disability in relapsing MS.
- Neuromyelitis Optica Spectrum Disorder (NMOSD): This medication is also indicated for treating NMOSD, a rare autoimmune disorder affecting the optic nerves and spinal cord. It functions similarly to how it does in MS by depleting B-cells and modulating the immune system's response.
Important Considerations:
- Prescription medication: Ocrelizumab is a powerful drug and should only be administered under the strict supervision of a qualified neurologist in a healthcare setting.
- Not a cure: It's crucial to understand that Ocrelizumab does not cure MS or NMOSD. However, it can help manage the relapses and slow down disease progression.
- Potential side effects: Like any medication, Ocrelizumab can cause various side effects, including:
- Infusion reactions (fever, chills, headache)
- Increased risk of infections due to suppressed immune system
- Headache
- Fatigue
- High blood pressure